Epidemiology of hepatitis D

Seminars in Liver Disease

Volumn 32, Issue 3, 2012, Pages 211-219

  Rizzetto, Mario ^a   Ciancio, Alessia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

HDV epidemiology; HDV prevalence; HDV transmission; HDV worldwide impact

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; DELTA AGENT HEPATITIS; DEVELOPING COUNTRY; ENDEMIC DISEASE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; INFECTION PREVENTION; ITALY; JAPAN; KOREA; MORBIDITY; MORTALITY; NORTH AMERICA; PAKISTAN; PREVALENCE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SOCIAL STATUS; SOUTH AMERICA; SOUTHERN EUROPE; SPAIN; TAIWAN; TURKEY (REPUBLIC); VACCINATION; VIRUS TRANSMISSION;

AFRICA; ASIA; DEVELOPING COUNTRIES; EUROPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; PREVALENCE;

EID: 84865497443     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1323626     Document Type: Article

References (121)

1. Rizzetto M, Shih JW, Gerin JL. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol: 1980; 125 1 318 324 (Pubitemid 10040441)
2. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis: 1980; 141 5 590 602 (Pubitemid 10109828)
3. Rizzetto M. The delta agent. Hepatology: 1983; 3 5 729 737 (Pubitemid 13007702)
4. Rizzetto M, Bonino F, Verme G. Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis. Semin Liver Dis: 1988; 8 4 350 356 (Pubitemid 19045633)
5. Le Gal F, Gault E, Ripault MP., et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis: 2006; 12 9 1447 1450 (Pubitemid 44455228)
6. Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology: 1997; 234 1 160 167 (Pubitemid 27316617)
7. Le Gal F, Badur S, Hawajri NA., et al. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Arch Virol: 2012; 157 4 647 659
8. Esmaeli R, Alavian SM, Hajibeigi B., et al. Phylogenetic analysis of twenty-six cases of hepatitis delta virus isolates in Teheran, Iran. Hepat Mon: 2009; 9 3 196 200
9. Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutierrez MF, Carrilho FJ, Pinho JR. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol: 2011; 11 6 1462 1468
10. Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol: 2003; 70 1 74 80
11. Wu JC, Huang IA, Huang YH, Chen JY, Sheen IJ. Mixed genotypes infection with hepatitis D virus. J Med Virol: 1999; 57 1 64 67
12. Barros LM, Gomes-Gouvêa MS, Pinho JR., et al. Hepatitis delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves? Virus Res: 2011; 160 1-2 333 339
13. Kiesslich D, Crispim MA, Santos C., et al. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. J Infect Dis: 2009; 199 11 1608 1611
14. Su CW, Huang YH, Huo TI., et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology: 2006; 130 6 1625 1635
15. Watanabe H, Nagayama K, Enomoto N., et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol: 2003; 84 Pt 12 3275 3289 (Pubitemid 37540756)
16. Gomes-Gouvêa MS, Soares MC, Bensabath G., et al. Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region. J Gen Virol: 2009; 90 Pt 11 2638 2643
17. Rizzetto M, Ponzetto A, Forzani I. Hepatitis delta virus as a global health problem. Vaccine: 1990; 8 Suppl S10 S14, discussion S21-S23 (Pubitemid 20154748)
18. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol: 2010; 7 1 31 40
19. Rizzetto M, Hadziyannis S, Hannson B, Toukan A, Gust I. Hepatitis delta virus infection in the world: epidemiologic patterns and clinical expression. Gastroenterology International: 1992; 5 18 32
20. Ponzetto A, Negro F, Popper H., et al. Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees. Hepatology: 1988; 8 6 1655 1661 (Pubitemid 19021904)
21. Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol: 2010; 16 5 554 562
22. Tamura I, Ichimura H, Koda T, Katayama S, Kurimura O, Kurimura T. Hepatitis delta virus infection in different time periods in Japan. J Gastroenterol Hepatol: 1990; 5 4 407 410 (Pubitemid 20254143)
23. Arakawa Y, Moriyama M, Taira M., et al. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat: 2000; 7 5 375 381
24. Jeong SH, Kim JM, Ahn HJ., et al. [The prevalence and clinical characteristics of hepatitis-delta infection in Korea]. Korean J Hepatol: 2005; 11 1 43 50, PMID 15788884
25. Kim HS, Kim SJ, Park HW., et al. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol: 2011; 83 7 1172 1177
26. Echevarría JM, León P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica: 2003; 19 6 1583 1591
27. Sagnelli E, Stroffolini T, Ascione A., et al. Promoting Group. The epidemiology of hepatitis delta infection in Italy. J Hepatol: 1992; 15 1-2 211 215
28. Tsai JF, Margolis HS, Fields HA, Chang WY, Tsai JH. Hepatitis delta virus superinfection among patients with chronic hepatitis B in southern Taiwan. Scand J Infect Dis: 1990; 22 4 403 405 (Pubitemid 20266844)
29. Hsu HM, Wang YF, Lo SH., et al. Hepatitis D virus infection among intravenous drug abusers in Taiwan: analysis of risk factors and liver function tests. J Med Virol: 1990; 31 2 76 81
30. Lee SD, Wang JY, Wu JC, Chiang YT, Tsai YT, Lo KJ. Hepatitis B and D virus infection among drug abusers in Taiwan. J Med Virol: 1986; 20 3 247 252
31. Liaw YF, Chiu KW, Chu CM, Sheen IS, Huang MJ. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis: 1990; 162 5 1170 1172
32. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology: 1995; 22 6 1656 1660
33. Wu JC, Wang YJ, Hwang SJ., et al. Hepatitis D virus infection among prostitutes in Taiwan. J Gastroenterol Hepatol: 1993; 8 4 334 337
34. Centers for Disease Control (CDC). Delta hepatitisMassachusetts. MMWR Morb Mortal Wkly Rep: 1984; 33 35 493 494
35. Ponzetto A, Seeff LB, Buskell-Bales Z., et al. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology: 1984; 4 6 1111 1115 (Pubitemid 15192259)
36. Ponzetto A, Cohen BJ, Vandervelde EM, Mortimer PP. Delta agent in Britain. Lancet: 1983; 2 8359 1141 1142
37. Ljunggren KE, Hansson BG. Fulminant delta hepatitis among Swedish drug addicts. Scand J Infect Dis: 1986; 18 5 397 400 (Pubitemid 16017365)
38. Shattock AG, Kelly MG, Fielding J, Arthurs Y. Epidemic hepatitis B with delta-antigenaemia among Dublin drug-abusers. Ir J Med Sci: 1982; 151 11 334 338 (Pubitemid 13183686)
39. Rizzetto M. Hepatitis D: thirty years after. J Hepatol: 2009; 50 5 1043 1050
40. Buti M, Homs M, Rodriguez-Frias F., et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat: 2011; 18 6 434 442
41. Deertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int: 2008; 28 4 494 498 (Pubitemid 351411135)
42. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol: 1997; 12 11 747 751
43. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol: 2002; 40 8 3047 3049
44. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB.; Italian Hospitals' Collaborating Group. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol: 2009; 81 12 1999 2006
45. Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat: 2009; 16 12 883 894
46. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infectionnot a vanishing disease in Europe! Hepatology: 2007; 45 5 1331 1332, author reply 1332-1333 (Pubitemid 46775802)
47. Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Häussinger D. Socioepidemiological data on hepatitis delta in a German university clinicincrease in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol: 2003; 41 6 523 526 (Pubitemid 36798996)
48. Cross TJ, Rizzi P, Horner M., et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol: 2008; 80 2 277 282
49. Le Gal F, Castelneau C, Gault E., et al. Reply to Wedemeyer et al.: Hepatitis D virus infection. Not a vanishing disease in Europe! Hepatology: 2007; 45 1332 1333
50. Manesis EK, Vourli G, Dalekos G., et al. Prevalence and clinical course of chronic hepatitis D (CHD) in Greece during the last 3 decades. Poster #127. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/ SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
51. Viana S, Paraná R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg: 2005; 73 4 808 814 (Pubitemid 41446734)
52. Nunes HM, Monteiro MR, Soares MdoC. Prevalêncìa dos marcadores serológicos dos virus das hepatites B e D na area indigena Apyterewa do grupo. Parakanoä, Para Brasil. Cad Saude Publica: 2007; 23 11 2756 2766
53. Duarte MC, Cardona N, Poblete F., et al. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela. Trop Med Int Health: 2010; 15 8 924 933
54. Alvarado-Mora MV, Fernandez MF, Gomes-Gouvêa MS, de Azevedo Neto RS, Carrilho FJ, Pinho JR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian populationhow is the epidemiological situation? PLoS ONE: 2011; 6 4 e18888
55. Mendes-Correa MC, Gomes-Gouvêa MS, Alvarado-Mora MV., et al. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important? Int J Infect Dis: 2011; 15 12 e828 e832
56. Galizzi F J, Teixeira R, Fonseca JC, Souto FJ. Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units. Hepatol Int: 2010; 4 2 511 515
57. Manesis EK. Epidemiology of hepatitis D viral infection. Paper presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/ Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
58. Chlabicz S, Grzeszczuk A, Lapiski TW, Prokopowicz D, Panasiuk A. Search for hepatitis delta virus (HDV) infection in hepatitis C patients in north-eastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B. Eur J Epidemiol: 2003; 18 6 559 561 (Pubitemid 36899561)
59. Ho E, Deltenre P, Nkuize M., et al. Hepatitis B-delta virus co-infection in Belgium: retrospective and prospective data and comparison to HBV monoinfection. Poster #104-105. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific- Programme.aspx. Accessed May 21, 2012
60. Mihaljevic I, Lovric M, Stojic Vidovic M, Balia M, Jukic I. Seroprevalence of HDV in the population of HBsAg positive blood donors and patients tested in Croatian Institute of transfusion Medicine 2002-2010. Poster #130. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
61. Dimitrova NZ, Zhelev DIvanova, Antonov K, Mateva L. Clinical and virological characteristics of Bulgarian patients with chronic hepatitis D. Poster #82. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
62. Genné D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly: 2011; 141 w13176 10.4414/smw.2011.13176
63. Krekulowa L, Rehak V. HDV genotype 1 newly identified in population of injecting drug users in Prague, Czech Republic. Poster #117. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/ Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
64. Kucirka LM, Farzadegan H, Feld JJ., et al. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis: 2010; 202 6 845 852
65. Gish RG, Yi DH, Baqai SF, Mangahas MM, Clark MD, Kane SD. Characteristics of hepatitis delta in Northern California. Poster #94. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/ Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
66. Soriano V, Grint D, d'Arminio Monforte A., et al. Hepatitis delta in HIV-infected individuals in Europe. AIDS: 2011; 25 16 1987 1992
67. Flodgren E, Bengtsson S, Knutsson M., et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol: 2000; 38 9 3311 3316
68. Borresen ML, Olsen OR, Ladefoged K., et al. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. J Viral Hepat: 2010; 17 3 162 170
69. Tsatsralt-Od B, Takahashi M, Endo K., et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. J Med Virol: 2006; 78 5 542 550
70. Davaalkham D, Ojima T, Uehara R., et al. Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg: 2006; 75 2 365 369 (Pubitemid 46941362)
71. Shaikh MA, Shaikh WM, Solangi GA, Shaikh BA, Soomro MA. Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak: 2011; 21 1 23 25
72. Zaidi G, Idrees M, Malik FA., et al. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J: 2010; 7 283
73. Baig S, Siddiqui AA, Ahmed WU, Qureshi H, Arif A. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders. J Coll Physicians Surg Pak: 2009; 19 11 699 703
74. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol: 2007; 13 18 2604 2607 (Pubitemid 46938832)
75. Mumtaz K, Hamid SS, Adil S., et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol: 2005; 20 10 1503 1507 (Pubitemid 43961102)
76. Makuwa M, Mintsa-Ndong A, Souquière S, Nkoghé D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J Clin Microbiol: 2009; 47 7 2265 2268
77. Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R. High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J Clin Microbiol: 2011; 49 3 1162 1164
78. Khan A, Kurbanov F, Tanaka Y., et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol: 2008; 80 2 268 276
79. Nwokediuko SC, Ijeoma U. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. Niger J Clin Pract: 2009; 12 4 439 442
80. Mansour W, Malick Z, Sidiya A., et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritana. J Med Virol: 2012; 84 8 1186 1198
81. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection: 1990; 18 1 26 28 (Pubitemid 20061335)
82. Mohammad Alizadeh AH, Ranjbar M, Tehrani AS., et al. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. J Microbiol Immunol Infect: 2010; 43 6 519 523
83. Roshandel G, Semnani S, Abdolahi N., et al. Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. Pak J Biol Sci: 2007; 10 10 1751 1754 (Pubitemid 46607984)
84. Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei-Andabili SH. Clinical features and seroepidemiology of anti-HDV antibody in patients with chronic hepatitis B virus infection in Iran: A meta-analysis. Hepat Mon: 2011; 11 960 967
85. Torabi S, Ebrahim-Poor S, Maljaie H, Naqili B. Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran. Urmia Med J: 2002; 13 290 297
86. Somi MH, Farhang S, Miri SM, Pouri AA, Mjidi G, Alavian SM. The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? Trop Doct: 2009; 39 3 154 156
87. Zahedi MJ. Serologic prevalence of hepatitis D in HBsAg positive patients in Kerman, South of Iran. Kerman, Iran: Kerman University of Medical Sciences and Health Services; 2003
88. Parepa IR, Suceveanu AI, Suceveanu A, Mazilu L, Voinea F. Trends in epidemiology of hepatitis D virus infection among institutionalized children in Southeast Romania. Poster #140. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific- Programme.aspx. Accessed May 21, 2012
89. Voiculescu M, Iliescu L, Ionescu C., et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis: 2010; 19 1 43 48
90. Kondili LA, Cuko L, Chionne P., et al. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol: 2010; 22 2 167 171
91. Sadiku E, Basho J. Hepatitis delta virus in Albania. Poster #145. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/ SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
92. Quaglio G, Ramadani N, Pattaro C., et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol: 2008; 80 5 833 840 (Pubitemid 351500031)
93. Bayan K, Yilmaz S, Tuzun Y, Yildirim Y. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases. Hepatogastroenterology: 2007; 54 80 2198 2202
94. Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y, Yalniz M. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider. J Viral Hepat: 2011; 18 7 518 524
95. Farci P, Burroughs AK, Thomas HC, Shamma'a M. Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis. J Hepatol: 1987; 4 2 224 228 (Pubitemid 17044984)
96. Ramia S, El-Zaatari M, Sharara AI, Ramlawi F, Farhat B. Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon. Epidemiol Infect: 2007; 135 6 959 962 (Pubitemid 47616477)
97. Djebbi A, Rebai WK, Bahri O, Hogga N, Sadraoui A, Triki H. [Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients]. Pathol Biol (Paris): 2009; 57 7-8 518 523
98. el Zayadi A, Ponzetto A, Selim O, Forzani B, Lavarini C, Rizzetto M. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterology: 1988; 35 6 313 315 (Pubitemid 19031161)
99. Morcos MM, Mikhail TH, Hanna WM, Abdel-Fattah S, el-Rasad MM, Wassef EL. The prevalence of delta virus infection in chronic liver disease in Egyptian children in comparison with some other countries. Panminerva Med: 2000; 42 2 97 100
100. Elhaasi AF, Elzouki Y, Arabi B, Tobgi R. Prevalence of delta virus infection in patients with hepatitis B virus infection. Poster #87. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/ SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
101. Al-Traif I, Ali A, Dafalla M, Al-Tamimi W, Qassem L. Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia. Ann Saudi Med: 2004; 24 5 343 344 (Pubitemid 39377934)
102. Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis D in EMRO region: systematic review and meta-analysis. Hepat Mon, in press.
103. Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol: 2007; 22 12 2093 2100 (Pubitemid 350145633)
104. Viksna L, Krumina A, Shangirejeva A, Arsha F, Sondore V. Epidemiological and clinical aspects of delta virus infection patients in Latvia. Poster #118. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/ SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
105. Kamilov F. Musabaev Aliev B, Akhmedov U, Usmanova G, Fayzullaev H. Occult HDV infection. Poster #113. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific- Programme.aspx. Accessed May 21, 2012
106. Ilyassova BS, Isatullaev EA, Nersesov AV. Arystanova The serum levels of inflammatory cytokins in liver cirrhosis caused HBV and HDV infection. Poster #107. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ ISTANBUL2010/SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
107. Nersesov AV, Izatullayev YA, Palgova LK., et al. Clinical peculiarities of HDV-infection in Kazakhstan. Poster #133. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/ Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
108. Otunbayeva J, Isina G, Bazhikova A. Profile of HBV-infection with delta hepatitis among the patients in Kazakhstan. "Vek clinicso" medical center, obstetrics center of the MH of Kazakhstan. Poster #137. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/ Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
109. Ghazinyan HI, Asoyan AV, Shahapuni AR, Melik-Andreasyan GG. Clinical and epidemiological distribution of hepatitis delta. Poster #91. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/ Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
110. Kozhanova TV, Klushkina VV, Isaeva OV., et al. Prevalence of hepatitis delta virus infection in Tyva Republic, Russian Federation. Poster #119. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24-26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/ SCIENTIFIC/Pages/Interactive-Scientific-Programme.aspx. Accessed May 21, 2012
111. Tulisov A, McMahon BJ, Koch A., et al. Viral hepatitis in the Arctic. A review from a circumpolar workshop on viral hepatitis, ICCH13. Alaska Med: 2007; 49 2, Suppl 193 203
112. Cheng HH, Wang DQ, Minuk GY, Anand CM, Stowe TC, Buchan KA. The prevalence of antibody to delta virus in western Canada. Clin Invest Med: 1986; 9 3 156 159 (Pubitemid 16031658)
113. Rex KF, Krarup HB, Laurberg P, Andersen S. Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland. Scand J Gastroenterol: 2012; 47 6 692 701
114. Narang A, Gupta P, Kar P, Chakravarty A. A prospective study of delta infection in fulminant hepatic failure. J Assoc Physicians India: 1996; 44 4 246 247 (Pubitemid 126461990)
115. Bhattacharyya S, Dalal BS, Lahiri A. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta. Indian J Public Health: 1998; 42 4 108 112
116. Chakraborty P, Kailash U, Jain A., et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res: 2005; 122 3 254 257 (Pubitemid 41645196)
117. Saravanan S, Velu V, Kumarasamy N., et al. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg: 2008; 102 8 793 796
118. Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India: 2006; 19 4 203 217 (Pubitemid 44596410)
119. Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg: 2005; 99 7 483 484 (Pubitemid 40692059)
120. Ciancio A, Rizzetto M. Clinical patterns, epidemiology and disease burden of hepatitis D virus chronic liver disease. In: Margolis H, Alter M, Liang T, Dienstag J., eds. 10th International Symposium on Viral Hepatitis and Liver Disease. London International Medical Press: 2002; 271 275
121. Li J, Wang J, Tian K, Wang Y, Zhang L, Huang H. Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J Huazhong Univ Sci Technolog Med Sci: 2006; 26 2 221 224